优化亚酸衍生赫德曼因D:通过PPAR-γ/NF-κB/NLRP3路径向痛风性关节炎
Xinlin Zhu1, Yi Dong1, Ya Zhang2
1Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou 310000, China.
Journal of medicinal chemistry
|December 24, 2025
概括
赫德曼因D衍生物9a是一种海洋天然产品,通过向PPAR-γ/NF-κB通路,有效治疗痛风性关节炎. 这种新型化合物显示出开发新抗痛风疗法的前景.
科学领域:
- 海洋天然产品 化学 化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 痛风性关节炎的特点是单酸盐 (MSU) 晶体沉积和炎症,这给治疗带来了挑战.
- 目前的痛风治疗有局限性,需要新的治疗策略.
研究的目的:
- 调查海藻类类Herdmanine D (HDD) 作为痛风性关节炎的潜在治疗剂.
- 优化HDD衍生物以增强与氧酶增殖器激活受体γ (PPAR-γ) 的结合,并评估它们的抗痛风作用.
主要方法:
- 结构-活动关系 (SAR) 研究和计算建模用于优化HDD.
- 在体外测试中评估了NF-κB驱动的炎症前驱性细胞因子的抑制.
- 用于评估优化衍生物 (9a) 的疗效,使用了MSU诱导的痛风性关节炎的小鼠模型.
主要成果:
- 优化的HDD衍生物9a表现出强大的PPAR-γ结合亲和力和有利的药理动力学特性.
- 化合物9a在体外有效抑制了促炎性细胞因子,并在体内减轻了突炎和组织损伤.
- 在机械上,9a激活了PPAR-γ,抑制了NF-κB并减弱了NLRP3炎症酶组合.
结论:
- 赫德曼因D作为一个有前途的海洋支架,用于开发下一代抗治疗药物.
- 海洋天然产品的合理药物设计提供了一个可行的策略,以解决痛风治疗中未满足的临床需求.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
GPCR Desensitization
7.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K


